![Max Rosett](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Max Rosett
Financieel Directeur/CFO bij
IMMUNOME, INC.
Vermogen: 2 M $ op 31-07-2026
Profiel
Max Rosett currently works at Immunome, Inc. as CFO, Chief Accounting Officer & EVP-Operations since 2024.
Formerly, Mr. Rosett was Chief Operating Officer at MorphImmune, Inc. from 2022 to 2023 and Principal at Research Bridge Partners from 2021 to 2023.
Mr. Rosett completed graduate education at Georgia Institute of Technology in 2016 and undergraduate education at Yale University in 2012.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
IMMUNOME, INC. 0,09% | 23-07-2026 | 101.287 ( 0,09% ) | 2 M $ | 31-07-2026 |
Actieve functies van Max Rosett
| Bedrijven | Functie | Begin |
|---|---|---|
| IMMUNOME, INC. | Financieel Directeur/CFO | 02-01-2024 |
Eerdere bekende functies van Max Rosett
| Bedrijven | Functie | Einde |
|---|---|---|
Research Bridge Partners /Venture Capital/
 Research Bridge Partners /Venture Capital/ Investment ManagersFinance Research Bridge Partners invests in companies located in the United States. The firm focuses on a biomedical sector. It provides finance for seed stage capital requirements. | Corporate Officer/Principal | 01-11-2023 |
MorphImmune, Inc.
 MorphImmune, Inc. BiotechnologyHealth Technology Operates as a biotechnology company focused on developing oncology therapeutics | Operationeel Directeur | 01-10-2023 |
Opleiding van Max Rosett
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
84
Eerstegraads connecties
5
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 5 |
|---|---|
Immunome, Inc.
 Immunome, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company which discovers, develops and commercializes antibody therapeutics | Health Technology |
Georgia Institute of Technology
 Georgia Institute of Technology Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Yale University
 Yale University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Research Bridge Partners /Venture Capital/
Research Bridge Partners /Venture Capital/ Investment ManagersFinance Research Bridge Partners invests in companies located in the United States. The firm focuses on a biomedical sector. It provides finance for seed stage capital requirements. | Finance |
MorphImmune, Inc.
MorphImmune, Inc. BiotechnologyHealth Technology Operates as a biotechnology company focused on developing oncology therapeutics | Health Technology |
